Shares of Drug Manufacturer Perrigo Co. Increase After Q2 Profit and Revenue Beats
If you’re looking for a drug manufacturer to invest in, you should know that Perrigo Company plc (NYSE:$PRGO) saw its shares increase 12.2% in pre-market trade today. Why? It all started after the company posted …
Shares of Synergy Pharmaceuticals are Falling Today and This is Why
On August 10, Synergy Pharmaceuticals (NASDAQ:$SGYP) shares dropped as much as 13% in early morning trade. Why? The commercial-stage biopharmaceutical company reported a much higher loss than what Wall Street was expecting. Even though Synergy …
Mylan N.V. Lowers 2017 Forecast Due to Delays in New Drugs
On August 9, American pharmaceutical company Mylan N.V. (NASDAQ:$MYL) announced that delays in launching key new drugs and deteriorating prices for generics in the U.S. will hurt its profitability tremendously in 2017 and 2018. As …
Shares Slide After Endo International Lowers 2017 Revenue Forecast
Endo International PLC (NASDAQ:$ENDP) made the decision to lower its 2017 revenue forecast on Tuesday, August 8. The Malvern, Pennsylvania-based company said that it expects lower sales of branded drugs to add to the pricing …
Shares of Valeant Pharmaceuticals Rose Sharply Due to Management Guidance
Valeant Pharmaceuticals International (TSE:$VRX) saw its shares rise sharply in Tuesday’s trading session, as upper management announced tremendously promising progress in resolving financial and legal issues that had haunted its business for the past 2 …
Goldberg Law PC is Investigating Depomed, Inc.
The public has now been made aware that Goldberg Law PC has commenced an investigation of Depomed, Inc. (NASDAQ:$DEPO).
Goldberg Law PC, a national shareholder rights litigation firm, disclosed that it is investigating …
This is Why Teva Pharmaceutical Industries’ Stock is Still Falling
After a disappointing second-quarter earnings report, along with a lowered guidance on Thursday, August 3rd, pharmaceutical company Teva Pharmaceutical Industries (NYSE:$TEVA) saw its stock plummet. On Friday, August 4th, Teva’s stock has continued to fall. …
Pfizer Inc. Confirms FDA Approval of XELJANZ Today
On August 3, Pfizer Inc. (NYSE:$PFE) disclosed that the United States FDA’s Arthritis Advisory Committee (AAC) voted 10 to 1 to recommend approval of the proposed dose of tofacitinib. This will be used to treat …
Teva Pharmaceutical Posts Second-Quarter Earnings; Shares Drop More Than 18%
On Thursday, in morning trade, Teva Pharmaceutical (TLV:$TEVA) shares dropped more than 18%. It all started after the Petah Tikva, Israel-based company posted lower-than-expected second-quarter earnings.
The multinational pharmaceutical company missed estimates for …
Pfizer Stock Rises Slightly Thanks to BMO Upgrade
Pharmaceutical company Pfizer’s (NYSE:$PFE) stock went up by 0.46% by market close on Wednesday, August 2. The rise was mainly due to BMO (TSE:$BMO) Capital Markets upgrading the stock from “Market Perform” to “Perform”. BMO …